Unknown

Dataset Information

0

Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.


ABSTRACT: The 21st century has witnessed three outbreaks of coronavirus (CoVs) infections caused by severe acute respiratory syndrome (SARS)-CoV, Middle East respiratory syndrome (MERS)-CoV, and SARS-CoV-2. Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, spreads rapidly and since the discovery of the first COVID-19 infection in December 2019, has caused 1.2 million deaths worldwide and 226,777 deaths in the United States alone. The high amino acid similarity between SARS-CoV and SARS-CoV-2 viral proteins supports testing therapeutic molecules that were designed to treat SARS infections during the 2003 epidemic. In this review, we provide information on possible COVID-19 treatment strategies that act via inhibition of the two essential proteins of the virus, 3C-like protease (3CLpro ) or papain-like protease (PLpro ).

SUBMITTER: Anirudhan V 

PROVIDER: S-EPMC8014870 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7901237 | biostudies-literature
| S-EPMC8251167 | biostudies-literature
| S-EPMC8850931 | biostudies-literature
| S-SCDT-EMM-2022-15904 | biostudies-other
| S-EPMC7290442 | biostudies-literature
| S-EPMC7986205 | biostudies-literature
2021-04-24 | GSE166424 | GEO
| S-EPMC8877376 | biostudies-literature
| S-EPMC7688049 | biostudies-literature